Plain-English translation of NCT04527315 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at NYU Langone Health are creating a database to track how COVID-19 affects survivors' health long-term. The study will use imaging scans, heart tests, breathing tests, and blood work to understand whether and how COVID-19 damages the lungs and heart, and will also check on mental health and quality of life. You would be compared to people who never had COVID to see what differences exist.
Many COVID-19 survivors report ongoing health problems after leaving the hospital, but doctors don't yet fully understand how widespread or serious these long-term effects are. This study aims to create a clear picture of who is affected and how, so doctors can better help future patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would complete a series of tests to check your heart and lung health—including chest imaging, heart ultrasound (echo), breathing tests (spirometry), MRI scans, and blood tests. You would also answer questions about your mental health and quality of life. The study will track you over time to see how you recover, and you would be compared to people in a control group who never had COVID-19.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
NYU Langone Health
Enrollment target
~1,500 participants
Started
July 2020
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ashley Witzl
NYU Langone Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.